bioAffinity Technologies, Inc.
BIAF
$10.50
$1.5717.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.51M | 1.35M | 1.59M | 1.45M | 1.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.51M | 1.35M | 1.59M | 1.45M | 1.27M |
| Cost of Revenue | 1.09M | 928.60K | 900.10K | 942.20K | 1.02M |
| Gross Profit | 422.70K | 422.90K | 692.70K | 503.90K | 252.90K |
| SG&A Expenses | 2.86M | 3.24M | 3.04M | 2.21M | 2.21M |
| Depreciation & Amortization | 61.60K | 114.50K | 123.70K | 113.40K | 113.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.85M | 4.97M | 4.73M | 3.74M | 3.79M |
| Operating Income | -3.33M | -3.62M | -3.14M | -2.29M | -2.52M |
| Income Before Tax | -3.37M | -3.63M | -3.13M | -5.05M | -4.03M |
| Income Tax Expenses | -- | -- | 3.20K | 3.20K | 29.00K |
| Earnings from Continuing Operations | -3.37M | -3.63M | -3.14M | -5.05M | -4.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.37M | -3.63M | -3.14M | -5.05M | -4.06M |
| EBIT | -3.33M | -3.62M | -3.14M | -2.29M | -2.52M |
| EBITDA | -3.27M | -3.50M | -3.01M | -2.18M | -2.40M |
| EPS Basic | -9.66 | -12.12 | -10.53 | -71.05 | -76.08 |
| Normalized Basic EPS | -6.04 | -7.57 | -6.57 | -44.38 | -47.21 |
| EPS Diluted | -9.66 | -12.12 | -10.53 | -71.05 | -76.08 |
| Normalized Diluted EPS | -6.04 | -7.57 | -6.57 | -44.38 | -47.21 |
| Average Basic Shares Outstanding | 348.50K | 299.70K | 298.00K | 71.10K | 53.40K |
| Average Diluted Shares Outstanding | 348.50K | 299.70K | 298.00K | 71.10K | 53.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |